MedTrace Logo

rTMS for PTSD Comorbid With Major Depressive Disorder

NCT02273063 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-10-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see how well a treatment called "Repetitive Transcranial Magnetic Stimulation" works for patients who struggle with symptoms of both posttraumatic stress disorder and major depressive disorder.

Conditions

Interventions

DEVICE

Transcranial Magnetic Stimulation (TMS)

Up to 40 sessions of TMS delivered with the first 35 sessions delivered over 7 weeks, and final 5 treatments delivered in taper schedule over 3 weeks. Treatment is adjunct to ongoing stable pharmacotherapy.

Sponsors & Collaborators

  • Providence VA Medical Center

    collaborator FED

  • Neuronetics

    collaborator OTHER

  • Butler Hospital

    lead OTHER

Principal Investigators

  • Linda L Carpenter, M.D. · Butler Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-04-22
Completion
2016-04-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02273063 on ClinicalTrials.gov